PANHEPRIN Drug Patent Profile
✉ Email this page to a colleague
When do Panheprin patents expire, and what generic alternatives are available?
Panheprin is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in PANHEPRIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Panheprin
A generic version of PANHEPRIN was approved as heparin sodium by HOSPIRA on April 28th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PANHEPRIN?
- What are the global sales for PANHEPRIN?
- What is Average Wholesale Price for PANHEPRIN?
Summary for PANHEPRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PANHEPRIN at DailyMed |
US Patents and Regulatory Information for PANHEPRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | PANHEPRIN | heparin sodium | INJECTABLE;INJECTION | 005264-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | PANHEPRIN | heparin sodium | INJECTABLE;INJECTION | 005264-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | PANHEPRIN | heparin sodium | INJECTABLE;INJECTION | 005264-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | PANHEPRIN | heparin sodium | INJECTABLE;INJECTION | 005264-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | PANHEPRIN | heparin sodium | INJECTABLE;INJECTION | 005264-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
